Foghorn Therapeutics Cash Flow Statement (2020-2025) | FHTX

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -13.98M-15.74M-18.69M-21.10M-23.62M-23.76M-26.76M-28.51M-26.91M-27.31M-25.77M-28.89M-30.49M-29.49M-14.35M-24.11M-25.02M-22.98M-19.12M-19.50M-20.22M-18.79M-16.47M
Share-based Compensation 0.52M0.49M0.88M1.08M1.89M2.04M2.37M2.08M3.24M3.51M3.80M3.78M4.57M4.47M4.09M3.05M3.22M3.17M3.02M2.48M2.69M2.73M2.73M
Gains from Investment Securities -0.00M0.07M1.69M1.00M0.86M0.05M0.70M0.06M0.05M1.21M-0.01M
Cash from Operations -10.76M-12.60M2.73M-10.65M-23.15M-18.48M-20.50M11.88M271.53M-29.01M-19.99M-28.92M-31.18M-32.17M-27.21M-27.54M-29.34M-25.54M-21.00M-24.52M-23.97M-21.00M-18.86M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00M0.01M0.01M-0.10M-0.10M-0.04M0.33M0.43M0.57M0.77M0.73M0.66M0.49M0.55M0.70M1.78M1.57M0.82M0.45M0.36M
Amortization of Deferred Charges 0.06M0.06M0.05M0.06M0.09M0.09M0.09M0.06M
Depreciation & Amortization (CF) 0.30M0.20M0.30M0.53M0.80M0.80M0.80M0.81M0.81M0.80M0.90M0.82M0.90M0.80M0.90M0.90M0.83M0.80M0.70M0.72M0.83M0.90M0.90M
Change in Working Capital
Change in Account Payables 0.97M-1.25M-0.09M0.85M-0.75M0.49M0.41M-0.02M1.27M-1.44M1.62M0.16M1.69M-0.17M-0.44M-0.24M-0.63M-0.83M-1.35M0.33M0.28M-0.75M-0.11M
Change in Accured Expenses -0.02M0.84M-1.02M3.39M-2.61M0.91M1.95M2.40M-2.54M1.09M2.00M0.89M-2.15M-0.67M0.69M0.33M-2.81M-0.30M4.97M-2.42M-2.41M2.02M1.16M
Investing Activities
Capital Expenditures 1.47M1.80M5.42M7.49M1.79M1.21M0.23M0.08M0.25M0.36M0.33M0.27M0.64M0.47M0.08M0.04M0.10M0.02M0.31M0.48M0.03M0.02M
Change in Acquisitions & Divestments 25.00M94.47M20.00M53.13M19.00M56.00M38.10M56.37M76.57M42.37M44.26M58.46M48.15M63.45M62.42M80.55M76.00M39.58M
Cash from Investing Activities -1.02M-2.25M-5.42M-100.22M-3.26M77.09M-47.33M9.67M-159.41M-124.46M46.05M-6.51M29.50M39.13M38.43M37.38M27.09M-17.98M-61.31M22.29M29.40M33.83M35.57M
Financing Activities
Other financing activities 0.39M
Debt Issuance and Repayment
Long-Term Debt Repayments 15.03M21.20M
Change in Capital Stock
Shares Issued 0.25M0.03M0.58M121.27M0.06M0.11M0.51M41.53M0.38M1.03M0.33M0.02M0.10M0.10M1.39M0.19M1.17M102.23M0.14M0.25M0.05M
Preferred Shares Issued 41.92M
Misc.
Cash from Financing Activities 0.25M47.96M40.75M128.51M0.06M0.11M0.51M21.74M0.38M1.03M0.33M0.02M0.10M0.10M1.39M0.19M1.17M103.21M1.05M0.00M0.14M0.25M0.05M
Change in Cash -11.54M33.12M38.05M17.63M-26.35M58.72M-67.33M43.30M112.51M-152.44M26.40M-35.41M-1.57M7.06M12.60M10.03M-1.08M59.69M-81.27M-2.22M5.57M13.09M16.76M
Beginning Cash Balance 14.98M3.44M36.56M75.16M92.80M66.45M125.17M57.84M101.14M213.65M61.21M87.63M52.21M50.64M57.70M70.31M80.34M79.25M138.95M57.68M55.45M59.48M72.57M
Free Cash Flow -12.23M-14.39M-2.70M-18.14M-24.94M-19.69M-20.73M11.80M271.29M-29.38M-20.32M-29.19M-31.82M-32.64M-27.29M-27.58M-29.45M-25.55M-21.31M-25.00M-24.00M-21.02M-18.86M
Net Cash Flow -11.54M33.12M38.05M17.63M-26.35M58.72M-67.33M43.30M112.51M-152.44M26.40M-35.41M-1.57M7.06M12.60M10.03M-1.08M59.69M-81.27M-2.22M5.57M13.09M16.76M